Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Figure 2

Kaplan–Meier curves of progression-free survival in patients with nasopharyngeal cancer treated with capecitabine stratified by hand-foot syndrome (a), Eastern Cooperative Oncology Group Performance Status (b), and the presence of brain metastasis (c).

(a)

(b)

(c)